Determination of pentazocine in human whole blood and urine by gas chromatography/surface ionization organic mass spectrometry. 2000

H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
Department of Legal Medicine Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu 431-3192, Japan.

Pentazocine has been found to be measurable with much higher sensitivity by gas chromatography (GC)/surface ionization (SI) organic mass spectrometry (OMS) than by the conventional GC/electron ionization (EI) mass spectrometry. The compound was extracted from human whole blood and urine with Sep-Pak C(18) cartridges before analysis by GC/SIOMS; recoveries were > 96.6% for both samples. The calibration curves were linear in the range 6.25-100 ng ml(-1) and the detection limits were 500 pg ml(-1) of a sample by selected ion monitoring (SIM) with GC/SIOMS. The intra- and inter-day relative standard deviations for the determination of pentazocine in whole blood and urine were not greater than 9.6%. The sensitivity for pentazocine obtained by SI-SIM was about 60 times higher than that obtained by EI-SIM. To validate the present GC/SIOMS method for pentazocine, whole blood and urine samples collected from two volunteers 1-6 h after intramuscular injection of 15 mg of pentazocine were analyzed. The concentrations were 13.5-59.3 ng ml(-1) for whole blood and 0.39-4.00 microg ml(-1) for urine.

UI MeSH Term Description Entries
D010423 Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) Fortral,Lexir,Pentazocine Hydrochloride,Pentazocine Lactate,Talwin,Hydrochloride, Pentazocine,Lactate, Pentazocine
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D003915 Dextromethorphan Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity. d-Methorphan,Delsym,Dextromethorphan Hydrobromide,Dextromethorphan Hydrobromide, (+-)-Isomer,Dextromethorphan Hydrobromide, Monohydrate,Dextromethorphan Hydrochloride,Dextromethorphan, (+-)-Isomer,Racemethorphan,Hydrobromide, Dextromethorphan,Hydrochloride, Dextromethorphan
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid
D000996 Antitussive Agents Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. Antitussive,Antitussive Agent,Antitussive Drug,Cough Suppressant,Antitussive Drugs,Antitussives,Cough Suppressants,Agent, Antitussive,Agents, Antitussive,Drug, Antitussive,Drugs, Antitussive,Suppressant, Cough,Suppressants, Cough
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass

Related Publications

H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
August 1994, Clinical chemistry,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
August 1979, Biomedical mass spectrometry,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
September 2000, Journal of analytical toxicology,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
November 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
December 1996, Journal of chromatography. B, Biomedical applications,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
April 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
March 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
May 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
January 1999, Sudebno-meditsinskaia ekspertiza,
H Seno, and T Kumazawa, and A Ishii, and H Matsushima, and K Watanabe-Suzuki, and O Suzuki
July 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!